期刊文献+

医疗纠纷第三方调解的公信力分析 被引量:10

Analysis on Credibility of the Third-party Mediation of Medical Dispute
下载PDF
导出
摘要 为探讨影响医疗纠纷第三方调解公信力的主体性因素及提高其公信力的措施。采用结构式访谈法对第三方调解进行了研究。影响第三方调解公信力的主体性因素主要是调解主体的调解能力与调解形象。要提高调解能力,需招聘既懂法又懂医的调解员以提高调解员的专业能力,促进调解员工作专职化,以案件为主体组织团队相互配合完成调解工作,学习调解需要的法学与医学知识,建立调解医学专家库与法学专家库。提升第三方调解形象,需保障第三方调解的中立性,实施免费调解,医调委、医疗机构与媒体多渠道宣传第三方调解以提高知晓度,调解承诺合理并兑现。 To explore factors influencing the subjectivity of the third-party medical dispute mediation credibility and improve its credibility measures, this article researched the third-party medical dispute mediation using the structured interview method. It found that the third-party mediation subject ability and conciliation image were two kernel elements of credibility. In order to improve the ability of mediation, mediators need to recruit talented personnel of law and medicine which can improve the professional abilities, promote the professionalization of mediator job, complete mediation work in the case of case-oriented interaction of team members, learn knowledge of law and medicine, as well as establish expert database. In order to enhance the image of the third-party medical dispute mediation, we should keep the neutrality of the third-party medical dispute mediation, implement free mediation and multi--channel propaganda, and fulfill the reasonable promise of mediation.
出处 《医学与哲学(A)》 北大核心 2016年第2期53-56,共4页 Medicine & Philosophy:Humanistic & Social Medicine Edition
基金 2014年度教育部人文社会科学研究青年基金项目 项目编号:14YJCZH217 2014年度浙江省自然基金项目 项目编号:LY14G030024
关键词 调解主体 医疗纠纷 第三方调解 公信力 mediation subject, medical dispute, the third-party mediation, credibility
  • 相关文献

参考文献7

二级参考文献40

共引文献89

同被引文献62

  • 1黄婷婷,刘婧,汤纪东.医患纠纷鉴定意见的形成及其认证[J].中国司法鉴定,2012(6):142-144. 被引量:1
  • 2GOODNOUGH L T, SHANDER A, SPENCER. Bloodless medi cine:clinical care without allogeneic blood transfusion[J]. Transfu- sion,2003,43(5) :668-676.
  • 3NAGARSHETH N P, SHANDER A, MALOVANY R, et al. Bloodless surgery in a Jehovah's Witness patient with a 12. 7-kg uterine leiomyo- sarcoma[J]. J Surg Educ,2007,64(4) :212-219.
  • 4SHANDER A,FINK A,JAVIDROOZI M,et al. Appropriateness of Allogeneic Red Blood Cell Transfusion: The International Consen- sus Conference on Transfusion Outcomes[J]. Transfus Med Rev, 2011,25(3) :232-246.
  • 5YU X,HUANG Y,QU G,et al. Safety and current status of blood transfusion in China[J]. Lancet, 2010,375(9724) : 1420- 1421.
  • 6SILVER M, CORWIN MJ, BAZAN A, et al. Efficacy of recombi- nant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo- controlled trial[J]. Crit Care Med, 2006,34 (9) : 2310 - 2316.
  • 7MONK T G, GOODNOUGH L T, BRECHER M E, et al. A prospective randomized comparison of three blood conservation strategies for radical prostatectomy[J]. Anesthesiology, 1999,91 (1) : 24- 33.
  • 8SEGAL J B,BLASCO-COLMENARES E, NORRIS E J, et al. Pre- operative acute normovolemic hemodilution: a meta-analysis [J]. Transfusion, 2004,44(5) : 632- 644.
  • 9CLAY M A. Ethical and legal implications of bloodless medicine and sur- gery[J]. Journal of Intensive Care Medicine, 1999,14 (1) : 34- 40.
  • 10MOSKOWITZ D M,KLEIN J J,SHANDER A,et al. Predictors of transfusion requirements for cardiac surgical procedures at a blood conservation center[J]. Ann Thorac Surg,2004,77(2) :626-634.

引证文献10

二级引证文献34

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部